Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A
Clinical trial NCT00920218 · COMPLETED
Trial details
- NCT number
- NCT00920218
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-14
- Primary completion
- 2011-04-26
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.